97 related articles for article (PubMed ID: 38684755)
1. Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma.
Yang P; Huang G; Li Y; Yu L; Yin Z; Li Q
Sci Rep; 2024 Apr; 14(1):9824. PubMed ID: 38684755
[TBL] [Abstract][Full Text] [Related]
2. Identification of immunogenic cell death-related damage-related molecular patterns (DAMPs) to predict outcomes in patients with head and neck squamous cell carcinoma.
Zhang J; Shi X; Wang M; Zhai R; Wang M; Gong Z; Ni Z; Xu T; Zhu W; Liu L
J Cancer Res Clin Oncol; 2024 May; 150(5):240. PubMed ID: 38713284
[TBL] [Abstract][Full Text] [Related]
3. Expression of RIPK1 and FADD are associated with chemosensitivity and survival in head and heck squamous cell carcinoma via tanshinone IIA-mediated modulation of the RIPK1-FADD-Caspase 8 complex.
Shen B; Han W; Tan X; Gu KJ; Naseem DF; Zheng G; Li G; Lou J; Chen C
Mol Carcinog; 2024 Jul; 63(7):1406-1416. PubMed ID: 38695620
[TBL] [Abstract][Full Text] [Related]
4. Single-Cell Molecular Profiling of Head and Neck Squamous Cell Carcinoma Reveals Five Dysregulated Signaling Pathways Associated With Circulating Tumor Cells.
Stucky A; Viet CT; Aouizerat BE; Ye Y; Doan C; Mundluru T; Sedhiazadeh P; Sinha UK; Chen X; Zhang X; Li SC; Cai J; Zhong JF
Cancer Control; 2024; 31():10732748241251571. PubMed ID: 38869038
[TBL] [Abstract][Full Text] [Related]
5. FAP is a prognostic marker, but not a viable therapeutic target for clinical translation in HNSCC.
Liu J; Ouyang Y; Xia Z; Mai W; Song H; Zhou F; Shen L; Chen K; Li X; Zhuang SM; Liao J
Cell Oncol (Dordr); 2024 Apr; 47(2):623-638. PubMed ID: 37856075
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of a novel risk model based on cuproptosis‑associated m6A for head and neck squamous cell carcinoma.
Xing Z; Xu Y; Xu X; Yang K; Qin S; Jiao Y; Wang L
BMC Med Genomics; 2024 May; 17(1):137. PubMed ID: 38778403
[TBL] [Abstract][Full Text] [Related]
7. Identification of ACAA1 and HADHB as potential prognostic biomarkers based on a novel fatty acid oxidation-related gene model in head and neck squamous cell carcinoma: A retrospective study.
Wang WL; Jiang HJ; Shen ZL; Tang YL; Jiang J; Liang XH
Arch Oral Biol; 2024 Jul; 163():105982. PubMed ID: 38678878
[TBL] [Abstract][Full Text] [Related]
8. Construction of a nomogram for predicting HNSCC distant metastasis and identification of EIF5A as a hub gene.
Chen X; Zhang Y; Chen S; Yang Y; Sun G; Pan P
Sci Rep; 2024 Jun; 14(1):13367. PubMed ID: 38862693
[TBL] [Abstract][Full Text] [Related]
9. Insights into metastatic roadmap of head and neck cancer squamous cell carcinoma based on clinical, histopathological and molecular profiles.
Mastronikolis NS; Delides A; Kyrodimos E; Piperigkou Z; Spyropoulou D; Giotakis E; Tsiambas E; Karamanos NK
Mol Biol Rep; 2024 Apr; 51(1):597. PubMed ID: 38683372
[TBL] [Abstract][Full Text] [Related]
10. FAP Serves as a Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma.
Liao Z; Fan H; Weng J; Zhou J; Zheng Y
Anal Cell Pathol (Amst); 2024; 2024():8810804. PubMed ID: 38826849
[TBL] [Abstract][Full Text] [Related]
11. Lactate dehydrogenase B as a metabolism-related marker for immunotherapy in head and neck squamous cell carcinoma.
Xu X; Pan X; Fan Z; Xia J; Ren X
Cell Signal; 2024 Aug; 120():111200. PubMed ID: 38719019
[TBL] [Abstract][Full Text] [Related]
12. Alteration of SERPINH1 is associated with elevated expression in head and neck squamous cell carcinomas and its clinicopathological significance.
Murugesan D; Kannan B; As SG; Jayaseelan VP; Arumugam P
J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101811. PubMed ID: 38432483
[TBL] [Abstract][Full Text] [Related]
13. USP39 Promotes the Viability and Migration of Head and Neck Squamous Cell Carcinoma Cell by Regulating STAT1.
Hu Y; Wang Y; Hu W; Hu C; Wang B; Liu C; Deng A; Shen B; Wu K; Liu Y
Technol Cancer Res Treat; 2024; 23():15330338241250298. PubMed ID: 38706215
[No Abstract] [Full Text] [Related]
14. A comprehensive analysis of LINC00958 as a prognostic biomarker for head and neck squamous cell carcinoma.
Li R; An P; Lin X; Liu X; Zhao L; He Y
Int J Oral Maxillofac Surg; 2024 Jun; 53(6):461-469. PubMed ID: 37923576
[TBL] [Abstract][Full Text] [Related]
15. Exploring the Role and Prognostic Value of TMEM208 in Head and Neck Squamous Cell Carcinoma.
Yang J; Song T
Asian Pac J Cancer Prev; 2024 Mar; 25(3):909-919. PubMed ID: 38546073
[TBL] [Abstract][Full Text] [Related]
16. FRZB: a potential prognostic marker for head and neck squamous cell carcinoma.
Li Y; Gu F; Huang X; Huang W; Xiang J; Yue J; Wang Y; Chen R
Braz J Med Biol Res; 2024; 57():e13368. PubMed ID: 38775547
[TBL] [Abstract][Full Text] [Related]
17. EXT2: a novel prognostic and predictive biomarker for head and neck squamous cell carcinoma.
Selvan AJA; Kannan B; Pandi C; Jayaseelan VP; Arumugam P
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Mar; 137(3):282-289. PubMed ID: 38155009
[TBL] [Abstract][Full Text] [Related]
18. EZH2 Expression in Head-and-Neck Squamous Cell Cancer in Young Patients.
Révész M; Oberna F; Slezák A; Tóth E; Ferenczi Ö; Kenessey I; Takácsi-Nagy Z
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791289
[TBL] [Abstract][Full Text] [Related]
19. Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma.
Benaiges E; Ceperuelo-Mallafré V; Guaita S; Maymó-Masip E; Madeira A; Gómez D; Hernández V; Vilaseca I; Merma C; León X; Terra X; Vendrell J; Avilés-Jurado FX; Fernández-Veledo S
Head Neck; 2024 Jul; 46(7):1752-1765. PubMed ID: 38305029
[TBL] [Abstract][Full Text] [Related]
20. Construction and validation of a folate metabolism-related gene signature for predicting prognosis in HNSCC.
Wang L; He Y; Bai Y; Zhang S; Pang B; Chen A; Wu X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):198. PubMed ID: 38625586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]